BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16094406)

  • 21. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
    Aksnes TA; Flaa A; Strand A; Kjeldsen SE
    J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of rennin-angiotensin-aldosterone system blockade in the prevention of nonvalvular atrial fibrillation].
    Qi WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):293-4. PubMed ID: 16776914
    [No Abstract]   [Full Text] [Related]  

  • 23. The renin-angiotensin system: a therapeutic target in atrial fibrillation.
    Patlolla V; Alsheikh-Ali AA; Al-Ahmad AM
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):1006-12. PubMed ID: 16981926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation and renin-angiotensin-aldosterone system: believe it or not.
    Fauchier L; de Groote P
    Europace; 2011 Mar; 13(3):297-8. PubMed ID: 21217131
    [No Abstract]   [Full Text] [Related]  

  • 25. A vaccine for hypertension.
    Ménard J
    J Hypertens; 2007 Jan; 25(1):41-6. PubMed ID: 17143170
    [No Abstract]   [Full Text] [Related]  

  • 26. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation.
    Anand K; Mooss AN; Hee TT; Mohiuddin SM
    Am Heart J; 2006 Aug; 152(2):217-22. PubMed ID: 16875900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Lyle PA; Tershakovec AM; Devereux RB; Oparil S; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Wedel H
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):729-45. PubMed ID: 16262560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dual blockade of the renin-angiotensin system--is it of clinical significance?].
    Pedersen OL
    Ugeskr Laeger; 2004 Oct; 166(43):3797. PubMed ID: 15544107
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
    Baumgart P
    MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of atrial fibrillation in hypertension.
    Aksnes TA; Flaa A; Strand A; Kjeldsen SE
    Curr Hypertens Rep; 2008 Jun; 10(3):175-81. PubMed ID: 18765086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.
    Dai SM; Zhang S; Chu JM; Guo YH; Chen KP; Yao Sy
    Med Hypotheses; 2007; 69(4):767-72. PubMed ID: 17475415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin-angiotensin system inhibitors and atrial fibrillation.
    Arbel Y; Glikson M
    Isr Med Assoc J; 2005 Jun; 7(6):388-91. PubMed ID: 15984384
    [No Abstract]   [Full Text] [Related]  

  • 38. The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target?
    Freestone B; Beevers DG; Lip GY
    J Hum Hypertens; 2004 Jul; 18(7):461-5. PubMed ID: 14973520
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
    Weber MA; Giles TD
    Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.